Machine Learning and Pregnancy Success Prediction in Fertility Treatments
MaLIV-PMA
Machine Learning-based Evaluation of Pregnancy Success Indicators in Assisted Reproductive Technology (ART) Cycles
1 other identifier
observational
5,000
1 country
1
Brief Summary
Infertility, as defined by the World Health Organization (WHO), is a disorder of the male or female reproductive system characterized by the inability to achieve a clinical pregnancy after 12 months or more of regular, unprotected sexual intercourse. In modern fertility treatment, assisted reproductive technologies (ART), including in vitro fertilization (IVF), have become a standard approach for addressing complex fertility issues and sterility. In Italy, infertility affects approximately 16.5% of couples. Despite advancements in ART, comparing the failure rates of pregnancies achieved through ART with those of spontaneous pregnancies in Italy reveals significant differences, particularly in terms of success rates, miscarriage rates, and embryo implantation outcomes. In this context, AI-based models have shown promising potential in predicting IVF success by analyzing complex datasets that include patient demographics, hormonal levels, and embryo morphology. Research indicates that AI can enhance embryo selection, predict the optimal timing for embryo transfer, and advance personalized medicine approaches in reproductive health. This study aims to use of Machine Learning to identify patterns and factors associated with successful pregnancy outcomes by analyzing large-scale, anonymized ART data. The resulting predictive model could enable clinicians to better personalize treatment protocols for each patient, optimizing medication dosages, timing, and embryo selection. It could also improve pregnancy success rates while reducing the emotional and financial burden on patients, thus advancing the standard of care in ART.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
March 19, 2025
CompletedStudy Start
First participant enrolled
April 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedOctober 7, 2025
October 1, 2025
11 months
March 13, 2025
October 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy rate
The primary endpoint of the study will be the clinical pregnancy defined as a pregnancy confirmed by an increasing level of hCG and the presence of a gestational sac or heartbeat detected by ultrasound.
Data will be extracted for all ART cycles conducted between 2019 and 2024 to allow for the comprehensive development of the Machine Learning-based model.
Study Arms (1)
IVF patients
Eligibility Criteria
Couples who received IVF treatment between 2019 and 2024
You may qualify if:
- Patients who underwent ART procedures, including IVF and ICSI, between 2019 and 2024.
- Women aged between 18 and 43 years.
You may not qualify if:
- Patiens with incomplete or missing data records that do not provide sufficient information for analysis.
- women outside the 18 to 43 age range
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS San Raffaele Hospital
Milan, Milano, 20132, Italy
Related Publications (5)
Zhang Q, Liang X, Chen Z. A review of artificial intelligence applications in in vitro fertilization. J Assist Reprod Genet. 2025 Jan;42(1):3-14. doi: 10.1007/s10815-024-03284-6. Epub 2024 Oct 14.
PMID: 39400647RESULTJiang VS, Bormann CL. Artificial intelligence in the in vitro fertilization laboratory: a review of advancements over the last decade. Fertil Steril. 2023 Jul;120(1):17-23. doi: 10.1016/j.fertnstert.2023.05.149. Epub 2023 May 19.
PMID: 37211062RESULTAttività del Registro Nazionale Italiano della Procreazione Medicalmente Assistita - 17° Report 2021
RESULTEuropean IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE); Smeenk J, Wyns C, De Geyter C, Kupka M, Bergh C, Cuevas Saiz I, De Neubourg D, Rezabek K, Tandler-Schneider A, Rugescu I, Goossens V. ART in Europe, 2019: results generated from European registries by ESHREdagger. Hum Reprod. 2023 Dec 4;38(12):2321-2338. doi: 10.1093/humrep/dead197.
PMID: 37847771RESULTInfertility prevalence estimates, 1990-2021. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 13, 2025
First Posted
March 19, 2025
Study Start
April 16, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
October 7, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share